Swing publishes Phase III data for fibromyalgia digital therapy
Swing Therapeutics has published positive results from the Phase III trial of its digital therapeutic, Stanza, for the treatment of…
Swing Therapeutics has published positive results from the Phase III trial of its digital therapeutic, Stanza, for the treatment of…
Immorna Biotherapeutics investigational new drug (IND) application for a Phase I/II study of its cancer therapeutic JCXH-211 intravenous (IV) has…
The Asia Pacific (APAC) region is leading the charge for adoptive cell therapy studies, says Scotty Chung-Siu, a managing analyst…
The first patients have been enrolled on a pilot programme launched by Pavmed’s digital health subsidiary Veris Health and the…
Anti-obesity drugs will be the most impactful trend of 2024, followed by personalised and precision medicine, immuno-oncology (IO) drug development,…
Adoptive cell therapy is a type of immunotherapy comprising cells that are engineered and expanded ex vivo and administered to…
AbbVie has announced positive data for its antibody-drug conjugate (ADC) therapies, Teliso-V, ABBV-400 and ABBV-706, from Phase I and II…
The uptake of decentralized clinical trials (DCTs) solutions was greatly accelerated by the COVID-19 pandemic, with lockdowns necessitating that research…
US-based Rakuten Medical has announced positive interim data from the Phase Ib/II trial of its photoimmunotherapy, ASP-1929, in combination with…
Merck & Co (MSD) has announced positive data for its antibody-drug conjugate (ADC) therapy, sacituzumab tirumotecan, from Phase II and…